Rinvoq Approved For Crohn’s Disease In Pivotal Year For AbbVie’s Immunology Business

7th US Indication For The JAK Inhibitor, 2nd In IBD

 
• By Mandy Jackson
  
Intestines health. Guts on pink background top view copy space
Rinvoq is now approved in the US for two inflammatory bowel disease indications • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip